Abad, C <br/><br/>
Pituitary adenylate cyclase-activating polypeptide inhibits collagen-induced arthritis: an experimental immunomodulatory therapy.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  Sep 2001 
 - 3182-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-1767 
<br/><br/><label>Standard No.: </label>10.4049/jimmunol.167.6.3182  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--pharmacology<br/>Adoptive Transfer<br/>Animals<br/>Anti-Inflammatory Agents, Non-Steroidal--pharmacology<br/>Arthritis, Experimental--drug therapy<br/>Arthritis, Rheumatoid<br/>Autoimmune Diseases--drug therapy<br/>B-Lymphocytes--drug effects<br/>Cattle<br/>Cells, Cultured<br/>Collagen--immunology<br/>Cytokines--biosynthesis<br/>Disease Models, Animal<br/>Drug Evaluation, Preclinical<br/>Enzyme Induction--drug effects<br/>Immunoglobulin G--biosynthesis<br/>Lymphocyte Count<br/>Male<br/>Matrix Metalloproteinase 2--biosynthesis<br/>Mice<br/>Mice, Inbred DBA<br/>Neuropeptides--pharmacology<br/>Pituitary Adenylate Cyclase-Activating Polypeptide<br/>Synovial Membrane--pathology<br/>T-Lymphocyte Subsets--immunology<br/>T-Lymphocytes, Regulatory--drug effects<br/>Th1 Cells--drug effects<br/>Th2 Cells--drug effects